<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0006876.ref021">
 <label>21</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Robbiani</surname>
   <given-names>DF</given-names>
  </name>, 
  <name>
   <surname>Bozzacco</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Keeffe</surname>
   <given-names>JR</given-names>
  </name>, 
  <name>
   <surname>Khouri</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Olsen</surname>
   <given-names>PC</given-names>
  </name>, 
  <name>
   <surname>Gazumyan</surname>
   <given-names>A</given-names>
  </name>
  <etal>et al</etal>
  <article-title>Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico</article-title>. 
  <source>Cell</source>. 
  <year>2017</year>;
  <volume>169</volume>(
  <issue>4</issue>): 
  <fpage>597</fpage>â€“
  <lpage>609</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2017.04.024" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/j.cell.2017.04.024</ext-link>
  <?supplied-pmid 28475892?>
  <pub-id pub-id-type="pmid">28475892</pub-id>
 </mixed-citation>
</ref>
